Chinese Biotech Firm Transcenta Raises $100M Round
January 8, 2020 — 22:53 CST
This Data Is Locked!
This area is available only to Subscribers.
Transcenta Holding, a Chinese biopharmaceutical company with the capabilities of drug discovery, process development, clinical development and process integration, announced the successful completion of a... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals